Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   arthritis, psoriatic
  

Disease ID 1154
Disease arthritis, psoriatic
Definition
A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.
Synonym
arthritic psoriasis
arthritis psoriatic
arthritis psoriatica
arthritis psoriatics
arthritis, psoriatic [disease/finding]
arthropathic psoriasis
arthropathies, psoriatic
arthropathy, psoriatic
pa (psoriatic arthritis)
pa - psoriatic arthritis
psa (psoriatic arthritis)
psa - psoriatic arthritis
psoriasis arthropathic
psoriasis arthropathica
psoriasis arthropathy
psoriasis with arthropathy
psoriasis with arthropathy (disorder)
psoriasis, arthritic
psoriasis, arthropathic
psoriatic arthritis
psoriatic arthritis (disorder)
psoriatic arthropathies
psoriatic arthropathy
psoriatic arthropathy nos
psoriatic arthropathy nos (disorder)
DOID
UMLS
C0003872
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:84)
C0033860  |  psoriasis  |  50
C0003864  |  arthritis  |  7
C0007222  |  cardiovascular disease  |  6
C0042373  |  vascular disease  |  6
C0021831  |  bowel disease  |  6
C0021390  |  inflammatory bowel disease  |  5
C0004153  |  atherosclerosis  |  5
C0038012  |  spondylitis  |  4
C0003873  |  rheumatoid arthritis  |  4
C0948265  |  metabolic syndrome  |  3
C0003864  |  inflammatory arthritis  |  3
C0011847  |  diabetes  |  3
C0039103  |  synovitis  |  3
C0021390  |  inflammatory bowel diseases  |  2
C0242490  |  enthesopathy  |  2
C0021053  |  immune disease  |  2
C0029456  |  osteoporosis  |  2
C0042164  |  uveitis  |  2
C0011570  |  depression  |  2
C0024299  |  lymphoma  |  1
C0878544  |  cardiomyopathy  |  1
C0079731  |  b-cell lymphoma  |  1
C0018213  |  graves disease  |  1
C0007570  |  celiac disease  |  1
C0002170  |  alopecia  |  1
C0033953  |  sexual dysfunction  |  1
C0020443  |  hypercholesterolemia  |  1
C0022073  |  iridocyclitis  |  1
C0026769  |  multiple sclerosis  |  1
C0028754  |  obesity  |  1
C0009782  |  connective tissue disease  |  1
C0042373  |  vascular diseases  |  1
C0007193  |  dilated cardiomyopathy  |  1
C1136085  |  monoclonal gammopathy  |  1
C0016053  |  fibromyalgia  |  1
C0009782  |  connective tissue diseases  |  1
C0019196  |  hepatitis c  |  1
C0018099  |  gout  |  1
C0036202  |  sarcoidosis  |  1
C0019360  |  zoster  |  1
C0002171  |  alopecia areata  |  1
C0027051  |  myocardial infarct  |  1
C0042870  |  vitamin d deficiency  |  1
C0334590  |  anaplastic oligodendroglioma  |  1
C0025202  |  melanoma  |  1
C0003467  |  anxiety  |  1
C0242647  |  marginal zone b-cell lymphoma  |  1
C0003509  |  aortitis  |  1
C0019163  |  hepatitis b  |  1
C0041296  |  tuberculosis  |  1
C0037315  |  sleep apnea  |  1
C0022408  |  joint disease  |  1
C0021400  |  influenza  |  1
C0032285  |  pneumonitis  |  1
C0949690  |  spondyloarthritis  |  1
C0029401  |  paget's disease  |  1
C0020498  |  diffuse idiopathic skeletal hyperostosis (dish)  |  1
C0442874  |  neuropathy  |  1
C0014118  |  endocarditis  |  1
C0026975  |  myelitis  |  1
C0019655  |  histoplasmosis  |  1
C0034069  |  pulmonary fibrosis  |  1
C0015397  |  eye disease  |  1
C0036202  |  sarcoid  |  1
C0025235  |  melkersson-rosenthal syndrome  |  1
C0007222  |  cardiovascular diseases  |  1
C0035078  |  renal failure  |  1
C0020492  |  hyperostosis  |  1
C0005940  |  bone disease  |  1
C0042870  |  vitamin d defic  |  1
C0031090  |  periodontal disease  |  1
C0007959  |  charcot-marie-tooth disease  |  1
C0520679  |  obstructive sleep apnea  |  1
C0158322  |  calcaneal spur  |  1
C0030312  |  pancytopenia  |  1
C0019158  |  hepatitis  |  1
C1956089  |  osteophyte  |  1
C0027051  |  myocardial infarction  |  1
C0036205  |  pulmonary sarcoidosis  |  1
C0023798  |  lipoma  |  1
C0024115  |  pulmonary disease  |  1
C0022661  |  chronic renal failure  |  1
C0020498  |  diffuse idiopathic skeletal hyperostosis  |  1
C0011849  |  diabetes mellitus  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:22)
3106  |  HLA-B  |  GHR
3123  |  HLA-DRB1  |  GHR
7124  |  TNF  |  CTD_human
4843  |  NOS2  |  CTD_human
149233  |  IL23R  |  GHR
3593  |  IL12B  |  CTD_human;GHR
79092  |  CARD14  |  GHR
652  |  BMP4  |  CTD_human
64127  |  NOD2  |  CTD_human
860  |  RUNX2  |  CTD_human
3576  |  CXCL8  |  CTD_human
4929  |  NR4A2  |  CTD_human
4210  |  MEFV  |  CTD_human
3107  |  HLA-C  |  CTD_human;GWASCAT;GHR
5966  |  REL  |  GWASCAT
3596  |  IL13  |  GHR
10758  |  TRAF3IP2  |  CTD_human;GWASCAT;GHR
400957  |  LINC01185  |  GWASCAT
4049  |  LTA  |  CTD_human
968  |  CD68  |  CTD_human
643749  |  TRAF3IP2-AS1  |  GWASCAT
54620  |  FBXL19  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:44)
3106  |  HLA-B  |  CIPHER
3107  |  HLA-C  |  CIPHER;CTD_human
3123  |  HLA-DRB1  |  CIPHER
3593  |  IL12B  |  CIPHER;CTD_human
100507436  |  MICA  |  CIPHER
4277  |  MICB  |  CIPHER
4790  |  NFKB1  |  CIPHER
5966  |  REL  |  CIPHER
100270953  |  RPL21P33  |  CIPHER
7124  |  TNF  |  CIPHER;CTD_human
10758  |  TRAF3IP2  |  CIPHER;CTD_human
7421  |  VDR  |  CIPHER
1493  |  CTLA4  |  CIPHER
1543  |  CYP1A1  |  CIPHER
1950  |  EGF  |  CIPHER
2246  |  FGF1  |  CIPHER
2247  |  FGF2  |  CIPHER
3105  |  HLA-A  |  CIPHER
3552  |  IL1A  |  CIPHER
3553  |  IL1B  |  CIPHER
3802  |  KIR2DL1  |  CIPHER
3803  |  KIR2DL2  |  CIPHER
3804  |  KIR2DL3  |  CIPHER
3806  |  KIR2DS1  |  CIPHER
100132285  |  KIR2DS2  |  CIPHER
4049  |  LTA  |  CIPHER;CTD_human
170679  |  PSORS1C1  |  CIPHER
10547  |  PSORS4  |  CIPHER
63870  |  PSORS5  |  CIPHER
26191  |  PTPN22  |  CIPHER
6648  |  SOD2  |  CIPHER
7132  |  TNFRSF1A  |  CIPHER
7133  |  TNFRSF1B  |  CIPHER
7157  |  TP53  |  CIPHER
7422  |  VEGFA  |  CIPHER
4210  |  MEFV  |  CTD_human
64127  |  NOD2  |  CTD_human
652  |  BMP4  |  CTD_human
4843  |  NOS2  |  CTD_human
3576  |  CXCL8  |  CTD_human
54620  |  FBXL19  |  CTD_human
968  |  CD68  |  CTD_human
4929  |  NR4A2  |  CTD_human
860  |  RUNX2  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:118)
176  |  ACAN  |  1.314  |  DISEASES
3899  |  AFF3  |  1.78  |  DISEASES
340351  |  AGBL3  |  2.768  |  DISEASES
10093  |  ARPC4  |  2.068  |  DISEASES
632  |  BGLAP  |  1.361  |  DISEASES
78996  |  C7orf49  |  1.228  |  DISEASES
79092  |  CARD14  |  3.666  |  DISEASES
54535  |  CCHCR1  |  2.36  |  DISEASES
6364  |  CCL20  |  1.553  |  DISEASES
1235  |  CCR6  |  1.082  |  DISEASES
9332  |  CD163  |  1.361  |  DISEASES
930  |  CD19  |  1.076  |  DISEASES
914  |  CD2  |  1.497  |  DISEASES
958  |  CD40  |  1.042  |  DISEASES
959  |  CD40LG  |  3.103  |  DISEASES
965  |  CD58  |  2.299  |  DISEASES
942  |  CD86  |  1.254  |  DISEASES
283420  |  CLEC9A  |  1.584  |  DISEASES
1260  |  CNGA2  |  1.672  |  DISEASES
57511  |  COG6  |  2.642  |  DISEASES
7180  |  CRISP2  |  1.678  |  DISEASES
55118  |  CRTAC1  |  1.978  |  DISEASES
1435  |  CSF1  |  1.654  |  DISEASES
6387  |  CXCL12  |  1.253  |  DISEASES
4283  |  CXCL9  |  1.778  |  DISEASES
2833  |  CXCR3  |  1.537  |  DISEASES
22943  |  DKK1  |  1.778  |  DISEASES
6993  |  DYNLT1  |  1.815  |  DISEASES
54620  |  FBXL19  |  4.161  |  DISEASES
2214  |  FCGR3A  |  1.6  |  DISEASES
2312  |  FLG  |  1.446  |  DISEASES
50943  |  FOXP3  |  1.272  |  DISEASES
2706  |  GJB2  |  1.004  |  DISEASES
2239  |  GPC4  |  1.131  |  DISEASES
10866  |  HCP5  |  2.49  |  DISEASES
3105  |  HLA-A  |  2.289  |  DISEASES
3106  |  HLA-B  |  3.581  |  DISEASES
3107  |  HLA-C  |  4.963  |  DISEASES
3123  |  HLA-DRB1  |  1.568  |  DISEASES
3127  |  HLA-DRB5  |  1.332  |  DISEASES
3240  |  HP  |  1.139  |  DISEASES
3376  |  IARS  |  2.421  |  DISEASES
3586  |  IL10  |  2.401  |  DISEASES
3590  |  IL11RA  |  1.343  |  DISEASES
3594  |  IL12RB1  |  2.074  |  DISEASES
3605  |  IL17A  |  4.859  |  DISEASES
112744  |  IL17F  |  2.705  |  DISEASES
23765  |  IL17RA  |  3.88  |  DISEASES
84639  |  IL1F10  |  2.651  |  DISEASES
50616  |  IL22  |  2.224  |  DISEASES
149233  |  IL23R  |  4.121  |  DISEASES
64806  |  IL25  |  1.647  |  DISEASES
90865  |  IL33  |  1.768  |  DISEASES
3683  |  ITGAL  |  2.184  |  DISEASES
3684  |  ITGAM  |  1.491  |  DISEASES
3716  |  JAK1  |  1.236  |  DISEASES
3718  |  JAK3  |  1.134  |  DISEASES
58494  |  JAM2  |  1.219  |  DISEASES
3802  |  KIR2DL1  |  1.286  |  DISEASES
3803  |  KIR2DL2  |  1.423  |  DISEASES
26085  |  KLK13  |  1.071  |  DISEASES
11202  |  KLK8  |  1.285  |  DISEASES
353142  |  LCE3A  |  2.193  |  DISEASES
353143  |  LCE3B  |  3.777  |  DISEASES
353144  |  LCE3C  |  3.953  |  DISEASES
84648  |  LCE3D  |  2.969  |  DISEASES
10186  |  LHFP  |  1.847  |  DISEASES
10288  |  LILRB2  |  1.695  |  DISEASES
126364  |  LRRC25  |  2.069  |  DISEASES
4049  |  LTA  |  2.466  |  DISEASES
11184  |  MAP4K1  |  1.384  |  DISEASES
4148  |  MATN3  |  1.26  |  DISEASES
79104  |  MEG8  |  1.912  |  DISEASES
100507436  |  MICA  |  3.399  |  DISEASES
4312  |  MMP1  |  1.745  |  DISEASES
4318  |  MMP9  |  1.135  |  DISEASES
345778  |  MTX3  |  1.248  |  DISEASES
26151  |  NAT9  |  1.421  |  DISEASES
4803  |  NGF  |  1.15  |  DISEASES
4892  |  NRAP  |  2.398  |  DISEASES
5142  |  PDE4B  |  1.949  |  DISEASES
11331  |  PHB2  |  4.664  |  DISEASES
51131  |  PHF11  |  1.063  |  DISEASES
23228  |  PLCL2  |  2.892  |  DISEASES
5478  |  PPIA  |  1.26  |  DISEASES
5627  |  PROS1  |  2.98  |  DISEASES
29968  |  PSAT1  |  1.38  |  DISEASES
23198  |  PSME4  |  1.65  |  DISEASES
26191  |  PTPN22  |  2.696  |  DISEASES
5901  |  RAN  |  1.392  |  DISEASES
55544  |  RBM38  |  1.425  |  DISEASES
6097  |  RORC  |  1.094  |  DISEASES
6283  |  S100A12  |  2.602  |  DISEASES
6280  |  S100A9  |  1.772  |  DISEASES
6288  |  SAA1  |  1.71  |  DISEASES
6401  |  SELE  |  2.274  |  DISEASES
5265  |  SERPINA1  |  1.499  |  DISEASES
256394  |  SERPINA11  |  2.314  |  DISEASES
5271  |  SERPINB8  |  1.714  |  DISEASES
653509  |  SFTPA1  |  2.485  |  DISEASES
729238  |  SFTPA2  |  2.278  |  DISEASES
59307  |  SIGIRR  |  2.324  |  DISEASES
84561  |  SLC12A8  |  2.114  |  DISEASES
6775  |  STAT4  |  1.095  |  DISEASES
7099  |  TLR4  |  1.448  |  DISEASES
7124  |  TNF  |  6.423  |  DISEASES
388121  |  TNFAIP8L3  |  2.117  |  DISEASES
7133  |  TNFRSF1B  |  7.191  |  DISEASES
8742  |  TNFSF12  |  1.416  |  DISEASES
10758  |  TRAF3IP2  |  4.237  |  DISEASES
7189  |  TRAF6  |  1.477  |  DISEASES
6738  |  TROVE2  |  1.008  |  DISEASES
7321  |  UBE2D1  |  1.516  |  DISEASES
10090  |  UST  |  2.915  |  DISEASES
7422  |  VEGFA  |  2.079  |  DISEASES
11326  |  VSIG4  |  1.293  |  DISEASES
55893  |  ZNF395  |  1.583  |  DISEASES
125893  |  ZNF816  |  3.008  |  DISEASES
Locus(Waiting for update.)
Disease ID 1154
Disease arthritis, psoriatic
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:52)
HP:0003765  |  Psoriasis  |  53
HP:0001369  |  Arthritis  |  7
HP:0100686  |  Enthesitis  |  7
HP:0002621  |  Atherosclerosis  |  5
HP:0012531  |  Pain  |  4
HP:0001370  |  Rheumatoid arthritis  |  4
HP:0100769  |  Synovitis  |  3
HP:0000716  |  Depression  |  2
HP:0000939  |  Osteoporosis  |  2
HP:0002664  |  Neoplasia  |  2
HP:0000554  |  Uveitis  |  2
HP:0002960  |  Autoimmune condition  |  2
HP:0002870  |  Obstructive sleep apnea  |  1
HP:0001658  |  Myocardial infarction  |  1
HP:0003493  |  Elevated antinuclear antibody  |  1
HP:0100647  |  Morbus Basedow  |  1
HP:0100665  |  Angiooedema  |  1
HP:0002459  |  Dysautonomia  |  1
HP:0002910  |  Elevated transaminases  |  1
HP:0012378  |  Fatigue  |  1
HP:0002829  |  Arthralgias  |  1
HP:0001596  |  Hair loss  |  1
HP:0002206  |  Pulmonary fibrosis  |  1
HP:0012115  |  Liver inflammation  |  1
HP:0001644  |  Congestive cardiomyopathy  |  1
HP:0000969  |  Dropsy  |  1
HP:0100512  |  Vitamin D deficiency  |  1
HP:0002104  |  Absence of spontaneous respiration  |  1
HP:0002608  |  Celiac disease  |  1
HP:0001298  |  Encephalopathy  |  1
HP:0003774  |  End-stage renal failure  |  1
HP:0002996  |  Decreased elbow mobility  |  1
HP:0001997  |  Gout  |  1
HP:0000819  |  Diabetes mellitus  |  1
HP:0010535  |  Sleep apnea  |  1
HP:0001094  |  Iridocyclitis  |  1
HP:0000083  |  Renal insufficiency  |  1
HP:0012060  |  Acral lentiginous melanoma  |  1
HP:0100774  |  Hyperostosis  |  1
HP:0002665  |  Lymphoma  |  1
HP:0000739  |  Anxiety  |  1
HP:0001876  |  Low blood cell count  |  1
HP:0012191  |  B-cell lymphoma  |  1
HP:0001638  |  Cardiomyopathy  |  1
HP:0002229  |  Alopecia areata  |  1
HP:0002861  |  Melanoma  |  1
HP:0001513  |  Obesity  |  1
HP:0008404  |  Dystrophic nails  |  1
HP:0012486  |  Inflammation of spinal cord  |  1
HP:0100584  |  Endocarditis  |  1
HP:0012032  |  Lipoma  |  1
HP:0003124  |  Elevated serum cholesterol  |  1
Disease ID 1154
Disease arthritis, psoriatic
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:26)
C0033860  |  psoriasis  |  51
C1282952  |  enthesitis  |  7
C0004153  |  atherosclerosis  |  5
C0239161  |  dactylitis  |  5
C0038012  |  spondylitis  |  4
C0030193  |  pain  |  4
C0003864  |  inflammatory arthritis  |  3
C0009450  |  infection  |  3
C0039103  |  synovitis  |  3
C0948265  |  metabolic syndrome  |  3
C0027339  |  nail disease  |  2
C0856169  |  endothelial dysfunction  |  2
C0037284  |  skin lesions  |  2
C0029456  |  osteoporosis  |  2
C0042164  |  uveitis  |  2
C0032285  |  pneumonitis  |  1
C0014118  |  endocarditis  |  1
C0238790  |  bone destruction  |  1
C1301700  |  cardiovascular morbidity  |  1
C0034069  |  pulmonary fibrosis  |  1
C0333243  |  pitting oedema  |  1
C0013604  |  oedema  |  1
C0270627  |  acute transverse myelitis  |  1
C0022408  |  joint disease  |  1
C0221260  |  nail dystrophy  |  1
C0015672  |  fatigue  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:44)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs10181656223287383798KIF5Aumls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012STAT42191105153GC
rs10181656223287386366CCL21umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012STAT42191105153GC
rs10181656223287386775STAT4umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012STAT42191105153GC
rs10181656223287383899AFF3umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0005428842012STAT42191105153GC
rs10181656223287383558IL2umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0005428842012STAT42191105153GC
rs1018165622328738940CD28umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012STAT42191105153GC
rs101816562232873823228PLCL2umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012STAT42191105153GC
rs111718062367328451561IL23Aumls:C0003872BeFreeAssociation study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis.0.0070773522013IL23A1256339747GA
rs11209026190403065079PAX5umls:C0003872BeFreeAll 3-marker sliding windows containing SNP rs11209026 were associated with PsA (p=0.02 for all 3 windows).0.0002714422009IL23R167240275GA
rs12188300209531863593IL12Bumls:C0003872GAD[We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 A 10a>>A1a*).]0.1351783392010NA5159402519AT
rs13017599223287383798KIF5Aumls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012NA260937196GA
rs13017599223287386366CCL21umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012NA260937196GA
rs13017599221704935966RELumls:C0003872GWASCATGenome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.0.1234527992012NA260937196GA
rs13017599223287383558IL2umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0005428842012NA260937196GA
rs13017599223287386775STAT4umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012NA260937196GA
rs13017599223287383899AFF3umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0005428842012NA260937196GA
rs130175992232873823228PLCL2umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012NA260937196GA
rs13017599221704935966RELumls:C0003872GAD[Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.]0.1234527992012NA260937196GA
rs1301759922328738940CD28umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012NA260937196GA
rs13190932209531863593IL12Bumls:C0003872BeFreeWe replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷).0.1351783392010TRAF3IP2;TRAF3IP2-AS16111591867GA
rs13190932209531863107HLA-Cumls:C0003872BeFreeWe replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷).0.2894784992010TRAF3IP2;TRAF3IP2-AS16111591867GA
rs13191343209531863107HLA-Cumls:C0003872GWASCATWe replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷).0.2894784992010HLA-C;LOC101929772631273332CG,T
rs13191343209531863107HLA-Cumls:C0003872GAD[We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 A 10a>>A1a*).]0.2894784992010HLA-C;LOC101929772631273332CG,T
rs1801282246975665468PPARGumls:C0003872BeFreeMeta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.0.0029099162014PPARG312351626CG
rs1805192246975665468PPARGumls:C0003872BeFreeMeta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.0.0029099162014PPARG312379739CG
rs20668082367328451561IL23Aumls:C0003872BeFreeAssociation study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis.0.0070773522013STAT21256344189AG
rs220184124910145149233IL23Rumls:C0003872BeFreeIL-23R gene polymorphism rs2201841 is associated with psoriatic arthritis.0.0157212222014IL23R167228519AG
rs2631367162550506584SLC22A5umls:C0003872BeFreeIn contrast, a functional SNP mapping to the promoter region of SLC22A5 (rs2631367) was associated with PsA (for CC versus GG, odds ratio 1.65, 95% confidence interval 1.13-2.41, uncorrected P = 0.005).0.0026384742005SLC22A5;LOC5531035132369766CG
rs3212227232970153593IL12Bumls:C0003872BeFreeMeta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis.0.1351783392012IL12B5159315942TG
rs3212227188001483593IL12Bumls:C0003872BeFreeFor both PA and PV, we detected the strongest association with two IL12B single-nucleotide polymorphisms and the corresponding haplotype as reflected by minimal P-values of 10(-7) and highest odds ratios of 1.50 (1.28-1.75) for rs6887695 in PA patients and 1.50 (1.27-1.76) for rs3212227 in the PV cohort, respectively.0.1351783392009IL12B5159315942TG
rs339805002095318810758TRAF3IP2umls:C0003872BeFreeA stratified analysis of our datasets including only PsA cases (1,922 cases compared to 8,037 controls, P = 4.57 × 10⁻¹² for rs33980500) suggested that TRAF3IP2 represents a shared susceptibility for PsV and PsA.0.2466341572010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs3398050020953186643749TRAF3IP2-AS1umls:C0003872GWASCATCommon variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.0.122010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002095318610758TRAF3IP2umls:C0003872GWASCATCommon variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.0.2466341572010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs339805002095318610758TRAF3IP2umls:C0003872GAD[Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.]0.2466341572010TRAF3IP2;TRAF3IP2-AS16111592059CT
rs4535211223287386775STAT4umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012PLCL2317031505AG
rs4535211223287383798KIF5Aumls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012PLCL2317031505AG
rs4535211223287383899AFF3umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0005428842012PLCL2317031505AG
rs4535211223287386366CCL21umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012PLCL2317031505AG
rs45352112232873823228PLCL2umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012PLCL2317031505AG
rs4535211223287383558IL2umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0005428842012PLCL2317031505AG
rs453521122328738940CD28umls:C0003872BeFreeSignificant evidence for association with susceptibility to PsA was found toa SNP mapping to the REL (rs13017599, p(trend)=5.2×10(4)) gene, while nominal evidence for association (p(trend)<0.05) was found to seven other loci including PLCL2 (rs4535211, p=1.7×10(-3)); STAT4 (rs10181656, p=3.0×10(-3)) and the AFF3, CD28, CCL21, IL2 and KIF5A loci.0.0002714422012PLCL2317031505AG
rs6887695232970153593IL12Bumls:C0003872BeFreeMeta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis.0.1351783392012NA5159395637GC
rs6887695188001483593IL12Bumls:C0003872BeFreeFor both PA and PV, we detected the strongest association with two IL12B single-nucleotide polymorphisms and the corresponding haplotype as reflected by minimal P-values of 10(-7) and highest odds ratios of 1.50 (1.28-1.75) for rs6887695 in PA patients and 1.50 (1.27-1.76) for rs3212227 in the PV cohort, respectively.0.1351783392009NA5159395637GC
rs70287322170493400957LINC01185umls:C0003872GWASCATGenome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.0.122012LINC01185260854407CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:5)
CHR POS SNPID REF ALT ORI_SNPID PMID P_VALUE P_VALUE_TEXT OR/BETA CI95_TEXT GWAS_INITIAL_SAMPLE_SIZE SUB_POPULATION SUPER_POPULATION GWAS_TRAIT HPO_ID HPO_TERM DO_ID DO_TERM MESH_ID MESH_TERM EFO_ID EFO_TERM DOLITE_TERM RISK_ALLELE PUBLICATION_TYPE AA GENE_SYMBOL TYPE REFGENE
261081542rs702873CTrs702873221704932.00E-07NA1.2[1.13-1.28] 535 European ancestry cases; 3,432 European ancestry controlsEuropean(3967)ALL(3967)EUR(3967)ALL(3967)Psoriatic arthritisHPOID:0003765HPOID:0001369PsoriasisArthritisDOID:9008psoriatic arthritisD015535Arthritis, PsoriaticEFOID:0003778psoriatic arthritisPsoriasisArthritisNA
261164331rs13017599GArs13017599221704931.00E-08NA1.27[1.18-1.35] 535 European ancestry cases; 3,432 European ancestry controlsEuropean(3967)ALL(3967)EUR(3967)ALL(3967)Psoriatic arthritisHPOID:0003765HPOID:0001369PsoriasisArthritisDOID:9008psoriatic arthritisD015535Arthritis, PsoriaticEFOID:0003778psoriatic arthritisPsoriasisArthritisNA
5158829527rs12188300ATrs12188300209531867.00E-17NA1.7[1.50-1.93]572 German cases; 888 German controlsGerman(1460)ALL(1460)EUR(1460)ALL(1460)Psoriatic arthritisHPOID:0003765HPOID:0001369PsoriasisArthritisDOID:9008psoriatic arthritisD015535Arthritis, PsoriaticEFOID:0003778psoriatic arthritisPsoriasisArthritisrs12188300-T
631241109rs13191343CTrs13191343209531862.00E-72NA2.37[2.16-2.61]572 German cases; 888 German controlsGerman(1460)ALL(1460)EUR(1460)ALL(1460)Psoriatic arthritisHPOID:0003765HPOID:0001369PsoriasisArthritisDOID:9008psoriatic arthritisD015535Arthritis, PsoriaticEFOID:0003778psoriatic arthritisPsoriasisArthritisrs13191343-T
6111913262rs33980500CTrs33980500209531861.00E-20NA1.95[1.69-2.24]572 German cases; 888 German controlsGerman(1460)ALL(1460)EUR(1460)ALL(1460)Psoriatic arthritisHPOID:0003765HPOID:0001369PsoriasisArthritisDOID:9008psoriatic arthritisD015535Arthritis, PsoriaticEFOID:0003778psoriatic arthritisPsoriasisArthritisrs33980500-T
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 1154
Disease arthritis, psoriatic
Case(Waiting for update.)